13 Million Americans Affected: Court Victory for Low-Income Patients as Mississippi’s 340B Law Stands

A federal judge has upheld Mississippi’s law requiring drugmakers to provide discounts on medications for low-income patients through third-party pharmacies.

Federal Judge Upholds Mississippi Law

A federal judge has upheld Mississippi’s law requiring drugmakers to provide discounts on medications for low-income patients through third-party pharmacies, according to the report of Benzinga Pro.

Pharmaceutical Industry Challenges

The Pharmaceutical Research and Manufacturers of America (PhRMA) and Novartis challenged the law, citing federal regulation conflicts. The judge denied their request for a preliminary injunction.

READ ALSO: Plug Power’s Georgia Facility: A Key Driver Of Future Success

(photo: Verity Solutions)

Patient Access

The decision is a victory for low-income patients who rely on the 340B program for affordable medications.

Contract Pharmacies

Contract pharmacies are at the center of the dispute, with concerns about transparency and potential abuses. Some companies have implemented restrictions on 340B drug sales via contract pharmacies.

Industry Response

Novartis will appeal the court’s decision, while states continue to pass laws requiring drugmakers to provide 340B discounts on contract pharmacy drugs.

READ ALSO: Growing A Healthier San Antonio: Innovative Solutions For Fresh Food Access